Securities Code: 002393 Securities Abbreviation: Life Pharmaceutical Announcement Number: 2026-014
Tianjin Life Pharmaceutical Co., Ltd. Announcement of Resolutions of the Fourth Meeting of the Eighth Board of Directors
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.
I. Convening of the Board Meeting
Tianjin Life Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "this Company") issued a notice for the Fourth Meeting of the Eighth Board of Directors in writing on March 17, 2026. The meeting was held on March 24, 2026, through a combination of on-site and written voting. The on-site meeting was held in the Company's conference room, presided over by Chairman Mr. Zhang Ping. Some senior management personnel attended the meeting. A total of 9 directors were eligible to attend, and 9 directors actually attended. This complies with the provisions of the "Company Law" and the "Articles of Association."
II. Deliberation of the Board Meeting
-
The meeting, with 9 votes in favor, 0 votes against, and 0 abstentions, approved the "Proposal on the 2025 General Manager's Work Report."
-
The meeting, with 9 votes in favor, 0 votes against, and 0 abstentions, approved the "Proposal on the 2025 Board of Directors' Work Report." This proposal needs to be submitted to the Company's 2025 Shareholders' Meeting for deliberation. Details can be found on the Juchao Information Network (www.cninfo.com.cn), China Securities Journal, and Securities Times.